25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ANGEN (Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret) Stock Analysis
Buy, Hold or Sell?

Let's analyze Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret together

I guess you are interested in Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret’s Financial Insights
  • 📈 Technical Analysis (TA) – Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret’s Price Targets

I'm going to help you getting a better view of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

I send you an email if I find something interesting about Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

1. Quick Overview

1.1. Quick analysis of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (30 sec.)










1.2. What can you expect buying and holding a share of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret? (30 sec.)

How much money do you get?

How much money do you get?
₺0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
₺7.46
Expected worth in 1 year
₺8.75
How sure are you?
86.7%

+ What do you gain per year?

Total Gains per Share
₺1.29
Return On Investment
10.1%

For what price can you sell your share?

Current Price per Share
₺12.78
Expected price per share
₺11.17 - ₺14.32
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (5 min.)




Live pricePrice per Share (EOD)
₺12.78
Intrinsic Value Per Share
₺-50.71 - ₺-61.11
Total Value Per Share
₺-43.25 - ₺-53.65

2.2. Growth of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (5 min.)




Is Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret growing?

Current yearPrevious yearGrowGrow %
How rich?$39m$27.9m$9.5m25.4%

How much money is Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret making?

Current yearPrevious yearGrowGrow %
Making money-$1.7m-$2.3m$626.8k35.4%
Net Profit Margin-51.3%-88.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret?

Welcome investor! Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's management wants to use your money to grow the business. In return you get a share of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

First you should know what it really means to hold a share of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret. And how you can make/lose money.

Speculation

The Price per Share of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is ₺12.78. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₺7.46. Based on the TTM, the Book Value Change Per Share is ₺0.32 per quarter. Based on the YOY, the Book Value Change Per Share is ₺0.63 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₺0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.01-0.1%-0.01-0.1%-0.01-0.1%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.010.1%0.020.1%0.010.1%0.010.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.010.1%0.020.1%0.010.1%0.010.1%0.010.1%
Usd Price Per Share0.24-0.28-0.33-0.43-0.48-0.48-
Price to Earnings Ratio-6.12--11.12--11.29-5.49-6.56-6.56-
Price-to-Total Gains Ratio82.87-47.33-86.73-67.71-53.99-53.99-
Price to Book Ratio1.35-1.66-2.79-4.09-4.63-4.63-
Price-to-Total Gains Ratio82.87-47.33-86.73-67.71-53.99-53.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.304164
Number of shares3287
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.010.01
Gains per Quarter (3287 shares)25.3046.37
Gains per Year (3287 shares)101.21185.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101019130156175
2020219260311360
3030429390467545
40405394120622730
50506495150778915
606075961799331100
7070869720910891285
8081079823912451470
9091189926914001655
1001012100029915561840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%4.08.00.033.3%7.08.00.046.7%7.08.00.046.7%7.08.00.046.7%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%12.03.00.080.0%12.03.00.080.0%12.03.00.080.0%
Dividend per Share0.00.04.00.0%6.00.06.050.0%6.00.09.040.0%6.00.09.040.0%6.00.09.040.0%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%13.02.00.086.7%13.02.00.086.7%13.02.00.086.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1210.323-62%0.634-81%0.288-58%0.497-76%0.497-76%
Book Value Per Share--7.4587.155+4%5.338+40%5.389+38%5.133+45%5.133+45%
Current Ratio--4.4127.341-40%11.216-61%14.373-69%17.095-74%17.095-74%
Debt To Asset Ratio--0.1730.142+22%0.115+51%0.103+68%0.089+93%0.089+93%
Debt To Equity Ratio--0.2090.166+26%0.130+61%0.117+79%0.101+106%0.101+106%
Dividend Per Share----0%0.062-100%0.119-100%0.096-100%0.096-100%
Enterprise Value--1870059314.0002336127144.000-20%2858260304.750-35%3824415771.917-51%4267175207.333-56%4267175207.333-56%
Eps---0.411-0.338-18%-0.458+11%-0.173-58%0.004-9279%0.004-9279%
Ev To Sales Ratio--2.9354.033-27%6.393-54%17.132-83%16.985-83%16.985-83%
Free Cash Flow Per Share---0.606-0.274-55%0.212-386%0.004-13732%0.119-607%0.119-607%
Free Cash Flow To Equity Per Share---0.606-0.274-55%0.212-386%-0.045-93%0.080-857%0.080-857%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---61.106----------
Intrinsic Value_10Y_min---50.707----------
Intrinsic Value_1Y_max---0.872----------
Intrinsic Value_1Y_min---0.854----------
Intrinsic Value_3Y_max---6.623----------
Intrinsic Value_3Y_min---6.242----------
Intrinsic Value_5Y_max---17.198----------
Intrinsic Value_5Y_min---15.618----------
Market Cap2811600000.000+21%2213200000.0002598750000.000-15%3016200000.000-27%3979433333.333-44%4397946666.667-50%4397946666.667-50%
Net Profit Margin---0.567-0.513-10%-0.881+55%-0.133-77%0.197-388%0.197-388%
Operating Margin----0%-0%-0.0080%-0.0060%-0.0060%
Operating Ratio--1.4311.383+3%1.184+21%1.354+6%1.176+22%1.176+22%
Pb Ratio1.714+21%1.3491.660-19%2.791-52%4.090-67%4.626-71%4.626-71%
Pe Ratio-7.780-27%-6.124-11.120+82%-11.292+84%5.490-212%6.563-193%6.563-193%
Price Per Share12.780+21%10.06011.813-15%13.710-27%18.088-44%19.991-50%19.991-50%
Price To Free Cash Flow Ratio-5.273-27%-4.151-18.572+347%-7.182+73%-11.024+166%-6.361+53%-6.361+53%
Price To Total Gains Ratio105.277+21%82.87147.328+75%86.727-4%67.712+22%53.987+54%53.987+54%
Quick Ratio--0.9201.240-26%2.551-64%3.951-77%4.711-80%4.711-80%
Return On Assets---0.046-0.040-12%-0.077+68%-0.022-52%0.017-376%0.017-376%
Return On Equity---0.055-0.047-15%-0.086+56%-0.026-52%0.016-434%0.016-434%
Total Gains Per Share--0.1210.323-62%0.696-83%0.408-70%0.593-80%0.593-80%
Usd Book Value--39047726.58837464466.871+4%27951357.715+40%28217278.572+38%26875486.072+45%26875486.072+45%
Usd Book Value Change Per Share--0.0030.008-62%0.015-81%0.007-58%0.012-76%0.012-76%
Usd Book Value Per Share--0.1770.170+4%0.127+40%0.128+38%0.122+45%0.122+45%
Usd Dividend Per Share----0%0.001-100%0.003-100%0.002-100%0.002-100%
Usd Enterprise Value--44507411.67355599826.027-20%68026595.253-35%91021095.372-51%101558769.935-56%101558769.935-56%
Usd Eps---0.010-0.008-18%-0.011+11%-0.004-58%0.000-9279%0.000-9279%
Usd Free Cash Flow---3172345.173-1432853.379-55%1109050.042-386%23270.587-13732%625161.129-607%625161.129-607%
Usd Free Cash Flow Per Share---0.014-0.007-55%0.005-386%0.000-13732%0.003-607%0.003-607%
Usd Free Cash Flow To Equity Per Share---0.014-0.007-55%0.005-386%-0.001-93%0.002-857%0.002-857%
Usd Market Cap66916080.000+21%52674160.00061850250.000-15%71785560.000-27%94710513.333-44%104671130.667-50%104671130.667-50%
Usd Price Per Share0.304+21%0.2390.281-15%0.326-27%0.431-44%0.476-50%0.476-50%
Usd Profit---2150359.726-1770224.109-18%-2397055.812+11%-1047074.810-51%-88184.571-96%-88184.571-96%
Usd Revenue--3790686.0713479792.389+9%2825164.559+34%2420510.533+57%2432874.010+56%2432874.010+56%
Usd Total Gains Per Share--0.0030.008-62%0.017-83%0.010-70%0.014-80%0.014-80%
 EOD+6 -2MRQTTM+7 -28YOY+12 -253Y+8 -295Y+8 -2910Y+8 -29

3.3 Fundamental Score

Let's check the fundamental score of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.780
Price to Book Ratio (EOD)Between0-11.714
Net Profit Margin (MRQ)Greater than0-0.567
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.920
Current Ratio (MRQ)Greater than14.412
Debt to Asset Ratio (MRQ)Less than10.173
Debt to Equity Ratio (MRQ)Less than10.209
Return on Equity (MRQ)Greater than0.15-0.055
Return on Assets (MRQ)Greater than0.05-0.046
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose12.300
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid extraction kits, and automated NA extraction instrument kits. The company provides products for diseases, such as brucellosis, chlamydia trachomatis, cytomegalovirus, crimean-congo hemorrhagic fever, novel coronavirus (2019-NCoV)/SARS-CoV-2, epstein-barr virus, hepatitis B, hepatitis C, hepatitis D, herpes simplex virus, human immunodeficiency virus, human papillomavirus, JC and BK polyomaviruses, malaria, measles, meningitis, respiratory infection, parvovirus B19, torque teno virus, toxoplasmosis, tuberculosis, ureaplasma, and west nile virus diseases, as well as factor II, factor V leiden, and methylene-tetra-hydro-folate-reductase mutation diseases. Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is headquartered in Istanbul, Turkey.

Fundamental data was last updated by Penke on 2025-10-25 00:51:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret earns for each ₤1 of revenue.

  • Above 10% is considered healthy but always compare Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret to the Medical Devices industry mean.
  • A Net Profit Margin of -56.7% means that ₤-0.57 for each ₤1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The MRQ is -56.7%. The company is making a huge loss. -2
  • The TTM is -51.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-56.7%TTM-51.3%-5.4%
TTM-51.3%YOY-88.1%+36.7%
TTM-51.3%5Y19.7%-71.0%
5Y19.7%10Y19.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-56.7%-4.5%-52.2%
TTM-51.3%-5.8%-45.5%
YOY-88.1%-11.0%-77.1%
3Y-13.3%-12.3%-1.0%
5Y19.7%-11.1%+30.8%
10Y19.7%-9.6%+29.3%
4.3.1.2. Return on Assets

Shows how efficient Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret to the Medical Devices industry mean.
  • -4.6% Return on Assets means that Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret generated ₤-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The MRQ is -4.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.6%TTM-4.0%-0.5%
TTM-4.0%YOY-7.7%+3.7%
TTM-4.0%5Y1.7%-5.7%
5Y1.7%10Y1.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.6%-1.4%-3.2%
TTM-4.0%-1.3%-2.7%
YOY-7.7%-2.4%-5.3%
3Y-2.2%-2.4%+0.2%
5Y1.7%-2.2%+3.9%
10Y1.7%-1.5%+3.2%
4.3.1.3. Return on Equity

Shows how efficient Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret to the Medical Devices industry mean.
  • -5.5% Return on Equity means Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret generated ₤-0.06 for each ₤1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The MRQ is -5.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.5%TTM-4.7%-0.8%
TTM-4.7%YOY-8.6%+3.9%
TTM-4.7%5Y1.6%-6.3%
5Y1.6%10Y1.6%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.5%-1.1%-4.4%
TTM-4.7%-1.3%-3.4%
YOY-8.6%-2.4%-6.2%
3Y-2.6%-3.2%+0.6%
5Y1.6%-3.9%+5.5%
10Y1.6%-3.9%+5.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is operating .

  • Measures how much profit Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret makes for each ₤1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated ₤0.00  for each ₤1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.6%+0.6%
5Y-0.6%10Y-0.6%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--10.0%+10.0%
TTM--12.8%+12.8%
YOY--13.3%+13.3%
3Y-0.8%-9.4%+8.6%
5Y-0.6%-9.0%+8.4%
10Y-0.6%-8.6%+8.0%
4.3.2.2. Operating Ratio

Measures how efficient Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.43 means that the operating costs are ₤1.43 for each ₤1 in net sales.

Let's take a look of the Operating Ratio trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The MRQ is 1.431. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.383. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.431TTM1.383+0.048
TTM1.383YOY1.184+0.199
TTM1.3835Y1.176+0.207
5Y1.17610Y1.1760.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4311.293+0.138
TTM1.3831.304+0.079
YOY1.1841.215-0.031
3Y1.3541.282+0.072
5Y1.1761.283-0.107
10Y1.1761.263-0.087
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 4.41 means the company has ₤4.41 in assets for each ₤1 in short-term debts.

Let's take a look of the Current Ratio trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The MRQ is 4.412. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.341. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.412TTM7.341-2.929
TTM7.341YOY11.216-3.876
TTM7.3415Y17.095-9.754
5Y17.09510Y17.0950.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4122.395+2.017
TTM7.3412.593+4.748
YOY11.2162.691+8.525
3Y14.3732.836+11.537
5Y17.0953.574+13.521
10Y17.0953.433+13.662
4.4.3.2. Quick Ratio

Measures if Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret to the Medical Devices industry mean.
  • A Quick Ratio of 0.92 means the company can pay off ₤0.92 for each ₤1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The MRQ is 0.920. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.240. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.920TTM1.240-0.320
TTM1.240YOY2.551-1.311
TTM1.2405Y4.711-3.471
5Y4.71110Y4.7110.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9201.324-0.404
TTM1.2401.458-0.218
YOY2.5511.724+0.827
3Y3.9511.896+2.055
5Y4.7112.290+2.421
10Y4.7112.521+2.190
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.17 means that Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret assets are financed with 17.3% credit (debt) and the remaining percentage (100% - 17.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The MRQ is 0.173. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.142. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.173TTM0.142+0.031
TTM0.142YOY0.115+0.027
TTM0.1425Y0.089+0.052
5Y0.08910Y0.0890.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1730.414-0.241
TTM0.1420.426-0.284
YOY0.1150.393-0.278
3Y0.1030.397-0.294
5Y0.0890.407-0.318
10Y0.0890.455-0.366
4.5.4.2. Debt to Equity Ratio

Measures if Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret to the Medical Devices industry mean.
  • A Debt to Equity ratio of 20.9% means that company has ₤0.21 debt for each ₤1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The MRQ is 0.209. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.166. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.209TTM0.166+0.043
TTM0.166YOY0.130+0.036
TTM0.1665Y0.101+0.064
5Y0.10110Y0.1010.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2090.642-0.433
TTM0.1660.667-0.501
YOY0.1300.584-0.454
3Y0.1170.646-0.529
5Y0.1010.632-0.531
10Y0.1010.753-0.652
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₤1 in earnings Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret generates.

  • Above 15 is considered overpriced but always compare Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret to the Medical Devices industry mean.
  • A PE ratio of -6.12 means the investor is paying ₤-6.12 for every ₤1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The EOD is -7.780. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.124. Based on the earnings, the company is expensive. -2
  • The TTM is -11.120. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.780MRQ-6.124-1.656
MRQ-6.124TTM-11.120+4.996
TTM-11.120YOY-11.292+0.172
TTM-11.1205Y6.563-17.684
5Y6.56310Y6.5630.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-7.780-0.733-7.047
MRQ-6.124-0.973-5.151
TTM-11.120-1.062-10.058
YOY-11.292-2.405-8.887
3Y5.490-1.052+6.542
5Y6.563-1.079+7.642
10Y6.563-1.014+7.577
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The EOD is -5.273. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.151. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -18.572. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.273MRQ-4.151-1.122
MRQ-4.151TTM-18.572+14.421
TTM-18.572YOY-7.182-11.390
TTM-18.5725Y-6.361-12.211
5Y-6.36110Y-6.3610.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-5.273-1.422-3.851
MRQ-4.151-1.745-2.406
TTM-18.572-1.503-17.069
YOY-7.182-3.237-3.945
3Y-11.024-2.198-8.826
5Y-6.361-3.739-2.622
10Y-6.361-3.976-2.385
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.35 means the investor is paying ₤1.35 for each ₤1 in book value.

Let's take a look of the Price to Book Ratio trends of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret:

  • The EOD is 1.714. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.349. Based on the equity, the company is underpriced. +1
  • The TTM is 1.660. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.714MRQ1.349+0.365
MRQ1.349TTM1.660-0.311
TTM1.660YOY2.791-1.131
TTM1.6605Y4.626-2.966
5Y4.62610Y4.6260.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.7142.291-0.577
MRQ1.3492.126-0.777
TTM1.6602.317-0.657
YOY2.7912.492+0.299
3Y4.0902.751+1.339
5Y4.6263.894+0.732
10Y4.6264.298+0.328
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in TRY. All numbers in thousands.

Summary
Total Assets1,983,801
Total Liabilities343,141
Total Stockholder Equity1,640,661
 As reported
Total Liabilities 343,141
Total Stockholder Equity+ 1,640,661
Total Assets = 1,983,801

Assets

Total Assets1,983,801
Total Current Assets733,890
Long-term Assets1,249,912
Total Current Assets
Cash And Cash Equivalents 123,024
Short-term Investments 18,376
Net Receivables 134,667
Inventory 350,201
Other Current Assets 1,356
Total Current Assets  (as reported)733,890
Total Current Assets  (calculated)627,623
+/- 106,267
Long-term Assets
Property Plant Equipment 793,811
Intangible Assets 449,532
Long-term Assets  (as reported)1,249,912
Long-term Assets  (calculated)1,243,343
+/- 6,568

Liabilities & Shareholders' Equity

Total Current Liabilities166,351
Long-term Liabilities176,790
Total Stockholder Equity1,640,661
Total Current Liabilities
Short Long Term Debt 61,713
Accounts payable 42,805
Total Current Liabilities  (as reported)166,351
Total Current Liabilities  (calculated)104,519
+/- 61,832
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt18,847
Long-term Liabilities  (as reported)176,790
Long-term Liabilities  (calculated)18,847
+/- 157,943
Total Stockholder Equity
Total Stockholder Equity (as reported)1,640,661
Total Stockholder Equity (calculated)0
+/- 1,640,661
Other
Capital Stock220,000
Common Stock Shares Outstanding 220,000
Net Invested Capital 1,702,374
Net Working Capital 567,539
Property Plant and Equipment Gross 793,811



6.2. Balance Sheets Structured

Currency in TRY. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-31
> Total Assets 
859,774
1,041,170
911,549
815,601
856,916
888,069
850,318
890,541
1,353,135
1,509,347
1,576,444
1,679,961
1,786,731
1,896,547
1,983,801
1,983,8011,896,5471,786,7311,679,9611,576,4441,509,3471,353,135890,541850,318888,069856,916815,601911,5491,041,170859,774
   > Total Current Assets 
708,029
850,906
717,469
608,201
625,059
646,083
590,221
599,627
729,725
768,987
760,986
755,107
758,170
749,610
733,890
733,890749,610758,170755,107760,986768,987729,725599,627590,221646,083625,059608,201717,469850,906708,029
       Cash And Cash Equivalents 
462,413
572,526
283,926
301,372
323,447
237,645
246,037
253,182
301,732
248,698
290,188
269,465
205,024
171,404
123,024
123,024171,404205,024269,465290,188248,698301,732253,182246,037237,645323,447301,372283,926572,526462,413
       Short-term Investments 
51,881
58,550
240,157
106,621
101,095
210,959
139,052
110,402
58,371
117,126
15,178
15,762
16,286
17,462
18,376
18,37617,46216,28615,76215,178117,12658,371110,402139,052210,959101,095106,621240,15758,55051,881
       Net Receivables 
99,029
99,941
62,880
70,520
82,591
51,828
69,794
68,197
77,924
90,051
91,215
92,785
107,375
126,230
134,667
134,667126,230107,37592,78591,21590,05177,92468,19769,79451,82882,59170,52062,88099,94199,029
       Inventory 
64,910
83,997
81,534
89,038
90,846
96,847
96,100
121,803
226,096
245,269
309,151
310,811
360,985
348,815
350,201
350,201348,815360,985310,811309,151245,269226,096121,80396,10096,84790,84689,03881,53483,99764,910
       Other Current Assets 
126
113
37
39,716
24,879
63
37,133
453
1,557
1,179
909
2,031
2,085
2,442
1,356
1,3562,4422,0852,0319091,1791,55745337,1336324,87939,71637113126
   > Long-term Assets 
151,745
190,264
194,080
207,400
231,856
241,986
260,097
290,914
623,410
740,360
815,458
924,854
1,028,560
1,146,938
1,249,912
1,249,9121,146,9381,028,560924,854815,458740,360623,410290,914260,097241,986231,856207,400194,080190,264151,745
       Property Plant Equipment 
0
0
0
167,290
187,429
191,172
202,106
214,130
461,854
533,964
579,197
599,144
636,329
696,257
793,811
793,811696,257636,329599,144579,197533,964461,854214,130202,106191,172187,429167,290000
       Intangible Assets 
22,849
29,624
32,859
38,380
43,393
50,026
56,558
73,786
159,242
203,718
228,848
321,617
380,412
444,620
449,532
449,532444,620380,412321,617228,848203,718159,24273,78656,55850,02643,39338,38032,85929,62422,849
       Other Assets 
0
0
0
30,706
38,083
0
46,523
0
0
0
0
0
0
0
0
0000000046,523038,08330,706000
> Total Liabilities 
33,982
35,967
31,412
33,036
40,514
51,966
52,444
77,097
139,884
194,378
220,399
189,392
235,365
282,593
343,141
343,141282,593235,365189,392220,399194,378139,88477,09752,44451,96640,51433,03631,41235,96733,982
   > Total Current Liabilities 
28,003
29,082
24,406
24,824
18,418
32,392
29,708
45,223
46,484
90,644
102,506
73,089
87,542
125,803
166,351
166,351125,80387,54273,089102,50690,64446,48445,22329,70832,39218,41824,82424,40629,08228,003
       Short Long Term Debt 
2,476
2,096
2,121
1,951
1,258
1,149
870
967
7,567
966
584
1,512
1,336
31,509
61,713
61,71331,5091,3361,5125849667,5679678701,1491,2581,9512,1212,0962,476
       Accounts payable 
7,867
14,140
3,964
12,216
7,813
16,660
14,080
15,710
10,846
38,274
33,412
21,632
46,437
35,912
42,805
42,80535,91246,43721,63233,41238,27410,84615,71014,08016,6607,81312,2163,96414,1407,867
       Other Current Liabilities 
8
17
2
5,610
2,578
69
4,460
26
0
0
0
0
0
0
0
0000000264,460692,5785,6102178
   > Long-term Liabilities 
5,979
6,885
7,006
8,211
22,097
19,574
22,736
31,874
93,400
103,734
117,893
116,304
147,823
156,790
176,790
176,790156,790147,823116,304117,893103,73493,40031,87422,73619,57422,0978,2117,0066,8855,979
       Long term Debt 
1,275
765
451
374
294
224
152
77
0
0
0
0
0
0
0
0000000771522242943744517651,275
       Capital Lease Obligations Min Short Term Debt
0
4,226
3,860
3,931
11,771
11,524
15,549
16,088
16,858
17,997
17,789
17,789
17,951
18,568
18,847
18,84718,56817,95117,78917,78917,99716,85816,08815,54911,52411,7713,9313,8604,2260
       Other Liabilities 
0
0
0
5,641
11,092
0
8,590
0
0
0
0
0
0
0
0
000000008,590011,0925,641000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
10,557
0
0
0
0
000010,5570000000000
       Deferred Long Term Liability 
0
0
0
28,977
37,049
0
45,091
0
0
0
0
0
0
0
0
0000000045,091037,04928,977000
> Total Stockholder Equity
766,737
933,804
880,137
782,565
816,401
836,103
797,874
813,443
1,213,251
1,314,968
1,356,044
1,490,569
1,551,366
1,613,954
1,640,661
1,640,6611,613,9541,551,3661,490,5691,356,0441,314,9681,213,251813,443797,874836,103816,401782,565880,137933,804766,737
   Common Stock
0
0
0
110,000
110,000
0
220,000
0
0
0
0
0
0
0
0
00000000220,0000110,000110,000000
   Retained Earnings 
423,898
568,443
478,080
436,559
457,471
411,644
421,261
337,730
-83,386
-155,616
-210,901
-300,559
-338,615
-478,016
-597,080
-597,080-478,016-338,615-300,559-210,901-155,616-83,386337,730421,261411,644457,471436,559478,080568,443423,898
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
0
0
0
21,007
30,086
0
47,768
0
0
0
0
0
0
0
0
0000000047,768030,08621,007000



6.3. Balance Sheets

Currency in TRY. All numbers in thousands.




6.4. Cash Flows

Currency in TRY. All numbers in thousands.




6.5. Income Statements

Currency in TRY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in TRY. All numbers in thousands.

Gross Profit (+$)
totalRevenue529,832
Cost of Revenue-195,263
Gross Profit334,569334,569
 
Operating Income (+$)
Gross Profit334,569
Operating Expense-512,465
Operating Income17,366-177,897
 
Operating Expense (+$)
Research Development3,140
Selling General Administrative80,096
Selling And Marketing Expenses0
Operating Expense512,46583,236
 
Net Interest Income (+$)
Interest Income3,350
Interest Expense-3,259
Other Finance Cost-0
Net Interest Income91
 
Pretax Income (+$)
Operating Income17,366
Net Interest Income91
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-168,73717,366
EBIT - interestExpense = -3,259
-218,876
-215,617
Interest Expense3,259
Earnings Before Interest and Taxes (EBIT)0-165,478
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-168,737
Tax Provision-50,139
Net Income From Continuing Ops-218,876-218,876
Net Income-218,876
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-91
 

Technical Analysis of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret. The general trend of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 14.08 < 14.20 < 14.32.

The bearish price targets are: 11.48 > 11.25 > 11.17.

Know someone who trades $ANGEN? Share this with them.👇

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Moving Average Convergence/Divergence (MACD) ChartAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret. The current adx is .

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Relative Strength Index (RSI) ChartAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Stochastic Oscillator ChartAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Commodity Channel Index (CCI) ChartAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Chande Momentum Oscillator (CMO) ChartAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Williams %R ChartAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Average True Range (ATR) ChartAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily On-Balance Volume (OBV) ChartAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Money Flow Index (MFI) ChartAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-06-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-04STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-08-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-08-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-08-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-09-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-09-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-10-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-10-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose12.300
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret with someone you think should read this too:
  • Are you bullish or bearish on Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

I send you an email if I find something interesting about Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.


Comments

How you think about this?

Leave a comment

Stay informed about Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret.

Receive notifications about Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.